ADORA2A rs113851554: What Your Genotype Means
The rs113851554 variant is a genetic marker located within the ADORA2A gene, which encodes the adenosine A2A receptor. Research suggests this variant may play a role in modulating sleep patterns and individual responses to caffeine consumption.
What each genotype means
Typical caffeine response
This genotype is associated with the baseline regulatory activity of the ADORA2A gene in studies of sleep and caffeine sensitivity. Research into this variant is limited, and while some ADORA2A variants influence how caffeine affects sleep architecture, the specific functional impact of rs113851554 remains an area of ongoing investigation. Please discuss any concerns regarding sleep quality or caffeine intake with your healthcare provider.
This is the most common genotype observed in populations of European ancestry.
Potential altered caffeine sensitivity
Carrying one copy of the T allele may be associated with subtle differences in how the ADORA2A gene regulates adenosine signaling, which is a key pathway for caffeine's wakefulness-promoting effects. Evidence for this specific variant is limited, and its role in individual sleep responses to caffeine is not yet fully established. You should consult with a clinician or pharmacist if you are evaluating how caffeine consumption impacts your personal sleep patterns.
This genotype is carried by approximately 8-12% of individuals of European ancestry.
Potential altered caffeine sensitivity
Carrying two copies of the T allele may be associated with variations in ADORA2A-mediated adenosine signaling, which can influence how the brain responds to caffeine. Because the evidence linking this specific variant to sleep outcomes is limited, it is unclear how this genotype influences your personal sensitivity to caffeine-induced sleep disruption. Please discuss your sleep health and caffeine habits with a qualified healthcare professional.
This genotype is relatively rare, occurring in approximately 1 in 400 to 1 in 600 individuals of European ancestry.
Understanding the Variant
The rs113851554 variant is a single nucleotide polymorphism (SNP) situated on chromosome 2 within the ADORA2A gene region. In genomics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is categorized as a regulatory SNP, meaning it is thought to influence how the ADORA2A gene is transcribed into protein rather than changing the structure of the protein itself. By modulating the expression levels of the adenosine A2A receptor, this variant may alter the sensitivity of neural pathways involved in sleep-wake cycles. Because it sits in a non-coding regulatory region, its functional impact is subtle and likely depends on the complex interplay between genetic background and environmental factors, such as daily caffeine intake.
The Role of the ADORA2A Gene
The ADORA2A gene provides instructions for creating the adenosine A2A receptor, a protein found on the surface of cells throughout the body, including the brain. Adenosine is a chemical that naturally builds up in the brain throughout the day, promoting sleepiness by binding to these receptors. Caffeine acts as an antagonist, meaning it blocks adenosine from binding to the A2A receptor, which is why it promotes wakefulness. Because the A2A receptor is central to this mechanism, variations in the ADORA2A gene can theoretically change how strongly caffeine binds or how the brain responds to adenosine levels. This gene is involved in various physiological processes, including the regulation of blood flow, immune responses, and the modulation of sleep architecture, particularly slow-wave sleep.
Research and Evidence Strength
Current evidence linking rs113851554 to specific traits is considered limited. While some genome-wide association studies have identified this SNP in relation to sleep-related phenotypes, the findings are often preliminary and require further replication across diverse cohorts. It is important to note that while other variants in the ADORA2A gene, such as rs5751876, have been extensively studied regarding caffeine sensitivity and sleep, rs113851554 is less characterized. Associations observed in research are statistical correlations, not direct causes. Factors such as age, sex, total daily caffeine dose, and other genetic modifiers can significantly influence sleep quality, making it difficult to isolate the effect of a single variant. Readers should view these associations as scientific observations rather than definitive predictors of personal health outcomes.
Population Frequency
The rs113851554 variant is relatively uncommon in the general population. Data indicates a minor allele frequency of approximately 4% to 6% in individuals of European ancestry. Because the frequency is low, the homozygous variant genotype is rare, meaning most individuals will carry either the common genotype or be heterozygous for the minor allele. Genetic frequency can vary significantly between different global populations, and current research is heavily skewed toward European cohorts. Consequently, the prevalence and potential impact of this variant in non-European populations remain largely under-studied. Understanding these frequencies is essential for researchers to determine the statistical power of studies and to avoid over-generalizing findings across diverse ancestral groups.
Interpreting Your Information
Information regarding genetic variants like rs113851554 is intended for educational purposes and should not be used to make medical decisions. Genetic markers do not provide a diagnosis for sleep disorders or determine your exact reaction to caffeine. If you are concerned about your sleep quality or the effects of caffeine on your health, it is best to consult with a healthcare professional or a sleep specialist. They can evaluate your symptoms, lifestyle, and medical history in a comprehensive manner. Never use genetic information to alter medication dosages or discontinue treatments without first discussing these changes with your clinician or pharmacist. Genetics is only one piece of a much larger puzzle that includes your environment, habits, and overall health status.
How common is this variant?
The minor allele frequency for rs113851554 is approximately 4-6% in European populations, making the homozygous minor genotype relatively rare.
Frequently asked questions
Can this genetic variant tell me if I am sensitive to caffeine?
While some ADORA2A variants are linked to caffeine sensitivity, rs113851554 is not a definitive test for how you will react to caffeine. Caffeine sensitivity is a complex trait influenced by many genes, your metabolism, and your daily habits.
Does this variant cause insomnia?
No, this variant does not cause insomnia. Research has shown statistical associations between certain ADORA2A variants and sleep patterns, but these are not diagnostic of any sleep disorder.
Should I change my coffee intake based on my genotype?
You should not change your caffeine intake based on a single genetic variant. If you have concerns about how caffeine affects your sleep, discuss your habits and symptoms with a healthcare provider.
Is this variant found in all populations?
Genetic variants often show different frequencies across ancestral groups. Much of the current research on this specific SNP has been conducted in European populations, and more data is needed to understand its frequency elsewhere.
Sources & further reading
Educational information only, last refreshed 9/24/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs113851554?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ADORA2A
The T allele of this variant is associated with increased caffeine-induced anxiety and sleep disturbances.
This variant is associated with individual differences in caffeine sensitivity and sleep patterns.
An adenosine A2A receptor variant that alters sensitivity to caffeine-induced anxiety, panic symptoms, and sleep architecture disruption.
A synonymous polymorphism tightly linked to rs1801175 in ADORA2A that modulates caffeine-provoked panic disorder susceptibility and electroencephalographic arousal.
Key adenosine A2A receptor regulatory variant influencing caffeine-induced sleep disturbance, slow-wave sleep reduction, and anxiety-related insomnia.